TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE

Aim. To study the influence of metabolic cytoprotector trimetazidine on the heart rate variability (HRV) in patients with stable ischemic heart disease (CHD).Material and methods. Into the simple, prospective, non-randomized trial totally 50 patients included with stable CHD, continuously showed pos...

Full description

Bibliographic Details
Main Authors: M. V. Novikova, M. G. Glezer
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2014-10-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/53